0001022079-17-000151.txt : 20170621
0001022079-17-000151.hdr.sgml : 20170621
20170621162804
ACCESSION NUMBER: 0001022079-17-000151
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170619
FILED AS OF DATE: 20170621
DATE AS OF CHANGE: 20170621
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: QUEST DIAGNOSTICS INC
CENTRAL INDEX KEY: 0001022079
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 161387862
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3 GIRALDA FARMS
CITY: MADISON
STATE: NJ
ZIP: 07940
BUSINESS PHONE: 9735202700
MAIL ADDRESS:
STREET 1: 3 GIRALDA FARMS
CITY: MADISON
STATE: NJ
ZIP: 07940
FORMER COMPANY:
FORMER CONFORMED NAME: CORNING CLINICAL LABORATORIES INC
DATE OF NAME CHANGE: 19960903
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cohen Jon R
CENTRAL INDEX KEY: 0001477972
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-12215
FILM NUMBER: 17923137
MAIL ADDRESS:
STREET 1: C/O QUEST DIAGNOSTICS INCORPORATED
STREET 2: 3 GIRALDA FARMS
CITY: MADISON
STATE: NJ
ZIP: 07940
4
1
wf-form4_149807686777487.xml
FORM 4
X0306
4
2017-06-19
0
0001022079
QUEST DIAGNOSTICS INC
DGX
0001477972
Cohen Jon R
C/O QUEST DIAGNOSTICS
3 GIRALDA FARMS
MADISON
NJ
07940
0
1
0
0
SVP & Group Exec. Diag. Sol.
Common Stock
2017-06-19
4
M
0
13680
57.605
A
86863
D
Common Stock
2017-06-19
4
M
0
29340
56.12
A
116203
D
Common Stock
2017-06-19
4
M
0
63880
52.165
A
180083
D
Common Stock
2017-06-19
4
S
0
13344
107.52
D
166739
D
Common Stock
2017-06-19
4
S
0
336
108.149
D
166403
D
Common Stock
2017-06-19
4
S
0
28182
107.527
D
138221
D
Common Stock
2017-06-19
4
S
0
1158
108.137
D
137063
D
Common Stock
2017-06-19
4
S
0
61321
107.529
D
75742
D
Common Stock
2017-06-19
4
S
0
2559
108.134
D
73183
D
Stock Options (Right to Buy)
57.605
2017-06-19
4
M
0
13680
57.605
D
2022-02-27
Common Stock
13680.0
0
D
Stock Options (Right to Buy)
56.12
2017-06-19
4
M
0
29340
56.12
D
2023-02-25
Common Stock
29340.0
0
D
Stock Options (Right to Buy)
52.165
2017-06-19
4
M
0
63880
52.165
D
2024-02-13
Common Stock
63880.0
0
D
This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 16, 2017.
This transaction was executed in multiple trades at prices ranging from $107.12 to $108.12. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $108.14 to $108.15. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $108.12 to $108.17. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $108.12 to $108.15. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
The options vested in three annual installments beginning with the first on February 27, 2012, the second February 27, 2013 and the final on February 27, 2014.
The options vested in three annual installments beginning with the first on February 25, 2013 the second on February 25, 2014 and the final on February 25, 2015.
The options vested in three annual installments beginning with the first on February 13, 2014, the second on February 13, 2015 and the final on February 13, 2016.
/s/ William J. O'Shaughnessy, Jr., Attorney in Fact for Jon R. Cohen
2017-06-21